1. Highlights from the DIA Ad-Promo Regulatory Affairs Conference 2017
An interactive session facilitated by:
Glenn N. Byrd, MBA, RAC
Senior Director, Specialty Care Promotional Regulatory Affairs
AstraZeneca, United States
(DIA Ad-Promo Program Committee Member)

2. DIA Ad-Promo Regulatory Affairs Conference 2017 Meeting Summary
Day 1
Morning - All about FDA
Afternoon – 2 breakouts and 1 Off-label comm talk
Close with FDA Q&A
Day 2
Early Morning Working Group Overview
Re-cap of Day 1
2 sets of breakouts
Patient Support Programs
FDA in the Trump administration

3. FDA Enforcement Overview FDA Draft Guidance and Initiatives
Day 1
FDA Enforcement Overview
FDA Draft Guidance and Initiatives
OPDP Research Agenda
Breakouts
Proactive communications to Population Health Decision Makers
Live and Field based tactics
Navigating the Murky Waters of Off-Label Communications
Q&A with FDA

4. Early morning session – DIA Ad-Promo Working Group Re-cap of Day 1
Mobile Apps – Promotion or Device?
Breakouts
Ad-Promo’s role in adoption of technology in our companies
Digital tactics
Developing a productive ad-promo team
Building and maintaining a productive FDA ad-promo relationship
Patient Support Programs
FDA in the Trump Administration